Evidence map›Paper›PMID 17825923›Full record

ReviewImmunology letters2007

Mimotope vaccines: epitope mimics induce anti-cancer antibodies.

Angelika B Riemer, Erika Jensen-Jarolim

Open access · greenAbstract readReview
In one paragraph

Review in Immunology letters, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Immunotherapeutic Strategies Targeting GD2-Expressing Malignancies.Advances in experimental medicine and biology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. A nanobody-derived mimotope against VEGF inhibits cancer angiogenesis.Journal of enzyme inhibition and medicinal chemistry · 2020
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. The roles of mast cells in anticancer immunity.Cancer immunology, immunotherapy : CII · 2012
    Review
  15. MimoDB 2.0: a mimotope database and beyond.Nucleic acids research · 2012
    Article
  16. Article
  17. Identification and characterization of Ch806 mimotopes.Cancer immunology, immunotherapy : CII · 2010
    Article
  18. Article
  19. Review
  20. SAROTUP: scanner and reporter of target-unrelated peptides.Journal of biomedicine & biotechnology · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Angelika B RiemerDepartment of Dermatology, Medical University Vienna, Austria.
Erika Jensen-Jarolim
Medical University of Vienna · AT

Funding

Austrian Science Fund FWF P 18238
6 · The paper itself

Abstract

Mimotopes are epitope-mimicking structures. When applied for immunizations they induce desired antibody specificities exclusively based on the principle of molecular mimicry. This is important as antibodies directed against tumor-associated antigens may harbor diverse biological effects depending on their epitope specificity. Thus they may inhibit or promote tumor growth. This review gives an update on different vaccination strategies based on the mimotope concept.

Indexed as

AnimalsAntibodies, NeoplasmAntigens, NeoplasmCancer VaccinesEpitopesHumansMolecular MimicryAntibodies, NeoplasmAntigens, NeoplasmCancer VaccinesEpitopes

Identifiers

PMID17825923
PMCPMC2999752
OpenAlexW2080450255

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.